Menu Search
Equities

Bluechiip Ltd

BCT:ASX

Bluechiip Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.003
  • Today's Change0.00 / 0.00%
  • Shares traded257.40k
  • 1 Year change-86.24%
  • Beta1.0262
Data delayed at least 20 minutes, as of Sep 27 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Bluechiip Ltd's revenues fell -47.03% from 915.04k to 484.69k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 5.04m to a larger loss of 5.81m.
Gross margin62.42%
Net profit margin-1,199.30%
Operating margin-1,168.64%
Return on assets-106.19%
Return on equity-378.30%
Return on investment-350.57%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Bluechiip Ltd fell by 1.55m. Cash Flow from Financing totalled 3.55m or 732.32% of revenues. In addition the company used 5.01m for operations while cash used for investing totalled 91.56k.
Cash flow per share-0.0109
Price/Cash flow per share--
Book value per share0.0006
Tangible book value per share0.0006
More ▼

Balance sheet in AUDView more

Bluechiip Ltd has a Debt to Total Capital ratio of 50.65%, a higher figure than the previous year's 3.61%.
Current ratio1.15
Quick ratio0.2818
Total debt/total equity1.03
Total debt/total capital0.5065
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.